While p53-null mice develop mostly lymphomas and soft tissue sarcomas (Donehower et al. 1992), mice expressing mutant p53 show a different tumor spectrum; developing more epithelial and endothelial tumors (Olive et al. 2004) and showing increased metastasis (Lang et al. 2004). Here, TP53 is linked to soft tissue sarcoma.